Key facts
- The Sabi’s last known valuation is $3.5M (Mar 2025).
- It has raised $860K; the latest was Seed Round ($550K) in Mar 2025.
- Notable investors include Cistern Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for The Sabi
- ·The full record, as it builds
Funding rounds
No funding rounds for The Sabi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About The Sabi
Operator of a hormonal wellness brand designed to support the complete hormonal journey through naturopathic principles. The company offers clinically backed, natural formulations that combine functional skincare with ingestible remedies, enabling individuals across key life stages, mentally and physically, to experience measurable well-being.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 9
- Website
- thesabi.co/
- Ownership
- Privately Held (backing)
The Sabi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in The Sabi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on The Sabi in its N-PORT filings yet. We sweep new filings monthly.